Tech Company Financing Transactions
Antidote Funding Round
Antidote secured a $5 million Seed venture capital round on 1/21/2026. Investors included Lakestar, Concept Ventures and The LegalTech Fund.
Transaction Overview
Company Name
Announced On
1/21/2026
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Seed
Investors
Proceeds Purpose
The new funding will support Antidote's next phase of growth, with a focus on advancing its AI-powered billing compliance platform and expanding its presence in the US.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
450 Park Ave. South 3rd floor
New York, NY 10016
USA
New York, NY 10016
USA
Phone
Website
Email Address
Overview
Antidote is a digital health company on a mission. Our aim is to accelerate the breakthroughs of potentially life-saving treatments, by bridging the gap between medical research and the people who need it.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Laurent Schockmel
Chief Financial Officer
Keith Lovell
Chief Technical Officer
Dean Sellis
VP - Bus. Development
Kathy Freeman
VP - Bus. Development
Thomas Krohn
VP - Human Resources
Nicola Yudaken
VP - Marketing
Grace McElroy
Browse more venture capital transactions:
Prev: 1/21/2026: Ultra venture capital transaction
Next: 1/21/2026: Finst venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs